-52.5%
NVTS vs THC
+306.8%
-359.3%
-92.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -15.2% | -0.2% | -15.1% | -15.2% |
| 7D | -32.1% | -8.0% | -24.1% | -30.4% |
| 30D | -33.6% | -2.2% | -31.4% | -33.1% |
| 3M | -53.1% | -3.5% | -49.7% | -52.7% |
| 6M | -73.6% | +40.4% | -114.0% | -77.0% |
| YTD | -14.8% | +32.4% | -47.3% | -25.2% |
| 1Y | -19.5% | +41.0% | -60.5% | -30.9% |
| 3Y | -14.2% | +305.2% | -319.5% | -58.9% |
| 5Y | -62.0% | +239.8% | -301.8% | -81.7% |
| All | -52.5% | +306.8% | -359.3% | -77.0% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling